Interventional Oncology Devices – Market Insights – Japan
The Japanese interventional oncology device market will grow slowly due to limited adoption of minimally invasive interventional oncology procedures, substantiated by Japanese guidelines and increasing developments in anticancer drugs, limiting the growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in Japan from 2019 to 2032.
Overcoming the short-term consequences that COVID-19 pandemic has had on the interventional oncology devices, the market has begun to see recovery toward prepandemic levels.
How did the COVID-19 pandemic affect the different segments of the interventional oncology device market?
How has the recovery of impacted procedures been through 2022?
How will trends in interventional oncology device market evolve in the post pandemic era?
Alternative forms of treatment are commonly used to treat cancer in Japan.
What alternatives compete with interventional oncology devices, and how well do they complement or compete with the existing products?
How does the Japanese regulatory environment impact the use of these alternative treatments compared to interventional oncology devices?
Regulatory approval delays will impact the interventional oncology device market in Japan.
How have regulatory approval delays impacted the Japanese interventional oncology device market?
What new devices are anticipated to enter the Japanese market within the forecast period, and when are they expected to launch?
Gelatin sponge particles represent a large portion of the Japanese embolization device market, while radioembolization particles have yet to commercially launch.
What are the recent developments in the radioembolization space and how have those developments impacted estimated launch of these products?
Why are gelatin sponge particles used in Japan more than other geographies, and which competitors have benefited from this scenario?
Table of contents
- Interventional Oncology Devices - Market Insights - Japan
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Interventional Oncology Device Market, by Product Type, Japan (USD), 2019u20132032
- Interventional Oncology Device Market Landscape, Japan (USD), 2022 and 2032
- Competitive Highlights
- Interventional Oncology Device Revenue Market Share Rankings, by Product Type, Japan, 2022
- Competitive Insights
- Companies Mentioned
- Market Developments
- Recent Events in the Interventional Oncology Device Market, Japan
- Key Clinical Trials in the Interventional Oncology Device Market, Japan
- Emerging Products for the Interventional Oncology Device Market, Japan
- Average Currency Exchange Rates
- Procedures Covered
- Interventional Oncology Procedures Covered, Japan
- Products Covered
- Interventional Oncology Products Covered, Japan
- COVID-19 Updates
- Key Report Updates
- Interventional Oncology Device Market
- Market Highlights
- Key Content Updates
- Japanese Interventional Oncology Device Market Drivers
- Japanese Interventional Oncology Device Market Limiters
- Interventional Oncology Device Market, by Product Type, Japan (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Interventional Oncology Procedures, by Procedure Type, Japan, 2019u20132032
- Interventional Oncology Procedures, by Indication, Japan, 2019u20132032
- Interventional Oncology Device Market, by Product Type, Japan (USD), 2019u20132032
- Interventional Oncology Device Market Growth, by Product Type, Japan, 2020u20132032
- Market Shares
- Interventional Oncology Device Revenue Market Shares, Japan, 2022
- Interventional Oncology Device Revenue Market Shares, by Product Type, Japan, 2022
- Market Developments
- Recent Events in the Interventional Oncology Device Market, Japan
- Key Clinical Trials in the Interventional Oncology Device Market, Japan
- Emerging Products for the Interventional Oncology Device Market, Japan
- Competitive Insights
- Boston Scientific Competitive Insights
- Medtronic Competitive Insights
- Terumo Competitive Insights
- Competitive Insights for Other Key Competitors
- Market Highlights
- Ablation Device Market
- Market Highlights
- Key Content Updates
- Japanese Ablation Device Market Drivers
- Japanese Ablation Device Market Limiters
- Ablation Device Market, by Product Type, Japan (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Ablation Procedures, by Indication, Japan, 2019u20132032
- Ablation Procedures, by Product Type, Japan, 2019u20132032
- Primary Liver Cancer Ablation Procedures, by Product Type, Japan, 2019u20132032
- Secondary Liver Cancer Ablation Procedures, by Product Type, Japan, 2019u20132032
- Kidney Cancer Ablation Procedures, by Product Type, Japan, 2019u20132032
- Lung Cancer Ablation Procedures, by Product Type, Japan, 2019u20132032
- Ablation Device Market, by Product Type, Japan (USD), 2019u20132032
- Ablation Device Market Growth, by Product Type, Japan, 2020u20132032
- RF Ablation Procedures, by Indication, Japan, 2019u20132032
- Microwave Ablation Procedures, by Indication, Japan, 2019u20132032
- Cryoablation Procedures, by Indication, Japan, 2019u20132032
- Market Shares
- Ablation Device Revenue Market Shares, Japan, 2022
- Ablation Device Revenue Market Shares, by Product Type, Japan, 2022
- Competitive Insights
- Market Highlights
- Embolization Device Market
- Market Highlights
- Key Content Updates
- Japanese Embolization Device Market Drivers
- Japanese Embolization Device Market Limiters
- Embolization Particle Market, by Product Type, Japan (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Embolization Particle Procedures, by Indication, Japan, 2019u20132032
- Embolization Particle Procedures, by Product Type, Japan, 2019u20132032
- Primary Liver Cancer Embolization Particle Procedures, by Product Type, Japan, 2019u20132032
- Kidney Cancer Embolization Particle Procedures, by Product Type, Japan, 2019u20132032
- Embolization Particle Market, by Product Type, Japan (USD), 2019u20132032
- Embolization Particle Market Growth, by Product Type, Japan, 2020u20132032
- Radioembolization Procedures, by Indication, Japan, 2019u20132032
- DEB Procedures, by Indication, Japan, 2019u20132032
- Microsphere Procedures, by Indication, Japan, 2019u20132032
- Gelatin Sponge Procedures, by Indication, Japan, 2019u20132032
- Market Shares
- Embolization Particle Revenue Market Shares, Japan, 2022
- Embolization Particle Revenue Market Shares, by Product Type, Japan, 2022
- Competitive Insights
- Market Highlights
- Accessory Device Market
- Market Highlights
- Key Content Updates
- Japanese Accessory Device Market Drivers
- Japanese Accessory Device Market Limiters
- Accessory Device Market, by Product Type, Japan (USD), 2019u20132032
- Market Definitions
- Market Forecast Data
- Accessory Device Market, by Product Type, Japan (USD), 2019u20132032
- Accessory Device Market Growth, by Product Type, Japan, 2020u20132032
- Market Shares
- Accessory Device Revenue Market Shares, Japan, 2022
- Accessory Devices Revenue Market Shares, Japan, 2022
- Competitive Insights
- Market Highlights
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Yukta Munjal is an associate analyst on the Cardiovascular Medtech Insights team at Clarivate, specializing in the peripheral vascular device market. Yukta holds a Bachelor’s degree in Pharmaceutical Sciences from Ram-Eesh Institute of Vocational and Technical Education, Greater Noida and M.Pharm in Pharmaceutical Analysis from Delhi Pharmaceutical Sciences and Research University, New Delhi.